NCT01893658 Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) Status WITHDRAWN Phase PHASE2
NCT01889069 A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) Status COMPLETED Phase PHASE3
NCT01888952 Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013) Status COMPLETED Phase EARLY_PHASE1
NCT01886209 Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01856192 Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01848132 Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI. Status COMPLETED Phase PHASE2
NCT01848067 Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01829958 Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy Status ACTIVE_NOT_RECRUITING Phase NA
NCT01818752 Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01814865 Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer Status WITHDRAWN Phase PHASE2
NCT01792687 Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate Status COMPLETED Phase PHASE1
NCT01791153 An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA) Status COMPLETED Phase PHASE3
NCT01786265 Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01782859 Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery Status COMPLETED Phase NA
NCT01780844 A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients Status COMPLETED Phase PHASE2
NCT01777152 ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Status COMPLETED Phase PHASE3
NCT01775475 Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01760226 Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies Status COMPLETED Phase EARLY_PHASE1